Arrhythmia Research Technology, Inc. Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2017; Provides Earnings Guidance for the Year 2018
March 26, 2018 at 08:39 am EDT
Share
Arrhythmia Research Technology, Inc. reported earnings results for the fourth quarter and year ended December 31, 2017. For the quarter, the company's net sales were $4,539,000 compared to $4,813,000 a year ago. Net loss was $364,000 or $0.13 per diluted share compared to $322,000 or $0.11 per diluted share a year ago. Adjusted EBITDA was $266,000 compared to $89,000 a year ago.
For the year, the company's net sales were $20,103,000 compared to $19,638,000 a year ago. Net loss was $1,355,000 or $0.48 per diluted share compared to $712,000 or $0.25 per diluted share a year ago. Adjusted EBITDA was $825,000 compared to $1,086,000 a year ago.
For the year 2018, the company expects revenue and EBITDA to improve.
Micron Solutions, Inc. is a diversified contract manufacturing organization (CMO). The Company, through its subsidiary, Micron Products, Inc., produces medical devices, military, and consumer components and assemblies requiring precision machining and custom injection molding. The Company provides design, engineering, quality and regulatory across the Companyâs three product lines: machining, thermoplastic injection molding and sensors. It machines components for implants and instruments for medical devices, including large joint replacements, wrist plates, rib fixation plates, and screws. Its custom thermoplastic injection molding services meet the needs of customers who require clean room molding, in-cycle vision inspection, assembly and packaging to tight tolerances using engineered materials. Its other value-added services include pad printing, ultrasonic welding, stamping, laser marking, clean room molding, clean room assembly, specialty coatings, plastic machining and others.
Arrhythmia Research Technology, Inc. Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2017; Provides Earnings Guidance for the Year 2018